AR056190A1 - Aciltriptofanoles, procedimiento para su preparacion, y composiciones farmaceuticas que los contienen - Google Patents

Aciltriptofanoles, procedimiento para su preparacion, y composiciones farmaceuticas que los contienen

Info

Publication number
AR056190A1
AR056190A1 ARP060103506A ARP060103506A AR056190A1 AR 056190 A1 AR056190 A1 AR 056190A1 AR P060103506 A ARP060103506 A AR P060103506A AR P060103506 A ARP060103506 A AR P060103506A AR 056190 A1 AR056190 A1 AR 056190A1
Authority
AR
Argentina
Prior art keywords
alkyl
alkylene
cycloalkyl
oxy
amine
Prior art date
Application number
ARP060103506A
Other languages
English (en)
Spanish (es)
Inventor
Lars Wortmann
Arwed Cleve
Bernd Menzenbach
Hans-Peter Muhn
Gernot Langer
Anna Schrey
Ronald Kuehne
Marcus Koppitz
Dirk Kosemund
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR056190A1 publication Critical patent/AR056190A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP060103506A 2005-08-10 2006-08-10 Aciltriptofanoles, procedimiento para su preparacion, y composiciones farmaceuticas que los contienen AR056190A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005038632A DE102005038632B4 (de) 2005-08-10 2005-08-10 Acyltryptophanole

Publications (1)

Publication Number Publication Date
AR056190A1 true AR056190A1 (es) 2007-09-26

Family

ID=37681170

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103506A AR056190A1 (es) 2005-08-10 2006-08-10 Aciltriptofanoles, procedimiento para su preparacion, y composiciones farmaceuticas que los contienen

Country Status (7)

Country Link
AR (1) AR056190A1 (de)
DE (1) DE102005038632B4 (de)
DO (1) DOP2006000187A (de)
GT (1) GT200600365A (de)
PE (1) PE20070406A1 (de)
TW (1) TW200716098A (de)
UY (1) UY29737A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008025893B4 (de) * 2008-05-26 2014-09-18 Technische Universität Dresden Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren

Also Published As

Publication number Publication date
GT200600365A (es) 2007-04-02
UY29737A1 (es) 2007-02-28
PE20070406A1 (es) 2007-05-12
DE102005038632B4 (de) 2008-03-27
DE102005038632A1 (de) 2007-02-15
DOP2006000187A (es) 2007-03-15
TW200716098A (en) 2007-05-01

Similar Documents

Publication Publication Date Title
PE20191475A1 (es) (aza)indol-, benzotiofen, y benzofuran-3-sulfonamidas
UY32149A (es) Formulaciones de glifosato que contienen agentes tensioactivos de amidoalquilaminas
CR9081A (es) Inhibidores de la interaccion entre mdm2 y p53
NO20071476L (no) Antidiuretiske midler.
MA30911B1 (fr) Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
ATE466860T1 (de) Cgrp-rezeptorantagonisten
AR068016A1 (es) Derivados de bencilbenceno, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por sglt
AR066617A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y emfermedades asociadas con angiogenesis
CR10190A (es) INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION (SOLICITUD DIVISIONAL EXP. 7332)
TNSN08311A1 (en) Indole sulfonamide modulators of progesterone receptors
PE20050013A1 (es) Composiciones farmaceuticas como inhibidores de la proteasa del virus de la hepatitis c
BRPI0411528A (pt) uso de isomalte como prebiótico
SG161310A1 (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
CY1109015T1 (el) Διφαινυλ ενωσεις χρησιμες ως ανταγωνιστες μουσκαρινικου υποδοχεα
TW200621725A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
PE20030135A1 (es) Derivados indol sustituido con triamida como inhibidores de la secrecion de mtp
PE20070078A1 (es) Compuestos heterociclicos macrociclicos como inhibidores de aspartil proteasa
CL2007003821A1 (es) Compuestos derivados de isoquinolina o isoquinolinona sustituidos con cicloalquilamina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades asociadas con la rho-quinasa y/o la fosforilacion mediada por la rho-quinasa de la cadena ligera de miosina, tales como hipertension, retinopatia, glaucoma, alzheimer, sida entre otras.
DE602005027230D1 (de) Cgrp-rezeptorantagonisten
TW200624424A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
PE20081781A1 (es) Agonistas de adrenoreceptores alfa2c funcionalmente selectivos
SE0403171D0 (sv) New compounds
ATE466853T1 (de) Cgrp-rezeptorantagonisten

Legal Events

Date Code Title Description
FB Suspension of granting procedure